天马国药 (873357.OC)

+ 收藏

利润表(天马国药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
关 闭
完整财报对比
2019年年报2019年中报2018年年报2018年三季报2018年中报
上市前/上市后 上市后上市前上市前上市前上市前
报表类型 合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 291,389,758.39143,175,394.22314,810,211.36215,055,869.37142,786,657.08
 营业收入(元) 291,389,758.39143,175,394.22314,810,211.36215,055,869.37142,786,657.08
二、营业总成本(元) 264,813,415.82131,774,669.84292,613,567.95200,280,388.19131,775,094.96
 营业成本(元) 248,416,700.21121,077,947.44268,023,331.49182,963,493.77121,016,543.22
 研发费用(元) 5,496,766.984,867,963.4010,003,851.626,878,094.134,172,055.35
 营业税金及附加(元) 1,190,286.36441,270.051,318,185.25910,863.07445,490.44
 销售费用(元) 2,331,107.911,260,393.744,436,733.353,617,282.572,112,996.76
 管理费用(元) 6,349,615.402,865,875.805,043,948.773,452,111.532,112,347.30
 财务费用(元) 1,028,938.96590,538.691,311,177.20980,006.62639,125.48
  其中:利息费用(元) 1,165,167.35671,272.661,331,259.41995,226.74647,441.91
  其中:利息收入(元) 142,944.2681,588.8225,503.3219,773.0610,869.64
三、其他经营收益
 资产处置收益(元) -269,914.08----
 资产减值损失(元) -670,680.722,476,340.271,478,536.501,276,536.41
 其他收益(元) 9,398,063.272,202,997.775,009,643.001,825,905.002,446,550.17
四、营业利润(元) 29,544,077.3613,603,722.1527,206,286.4116,601,386.1813,458,112.29
 加:营业外收入(元) 3,301,700.00----
 减:营业外支出(元) 43,752.00-78,246.3773,094.3753,077.97
五、利润总额(元) 32,802,025.3613,603,722.1527,128,040.0416,528,291.8113,405,034.32
 减:所得税费用(元) 23,622.9023,622.9021,567.6216,221.0216,221.02
六、净利润(元) 32,778,402.4613,580,099.2527,106,472.4216,512,070.7913,388,813.30
(一)按经营持续性分类
  持续经营净利润(元) 32,778,402.4613,580,099.2527,106,472.4216,512,070.7913,388,813.30
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 32,778,402.4613,580,099.2527,106,472.4216,512,070.7913,388,813.30
 扣除非经常性损益后的净利润(元) 22,250,219.8511,707,551.1522,175,100.0014,759,300.00-
七、每股收益
 一、基本每股收益(元) 0.560.230.740.570.23
 二、稀释每股收益(元) 0.560.230.740.570.23
九、综合收益总额(元) 32,778,402.4613,580,099.2527,106,472.4216,512,070.7913,388,813.30
 归属于母公司所有者的综合收益总额(元) 32,778,402.4613,580,099.25--13,388,813.30
公告日期 2020-04-242019-08-292019-07-302019-01-312019-08-29
审计意见(境内) 标准无保留意见标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院